Rep. Cleo Fields (D-LA) Buys QNT Shares Amid Insider and Analyst Activity

Democratic Representative Cleo Fields disclosed buying QNT shares in June.

Cleo Fields

Financial Disclosure Report

Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515

Filer Information

Name:
Rep. Cleo Fields (D-LA)
Status:
Member — House
State/District:
LA-6
Party:
democrat

Filing Information

Filing Type:
Periodic Transaction Report
Filing Year:
2026
Filing Date:
Jun 26, 2026

Schedule B: Transactions

AssetTransactionDateAmount
Quantinuum Inc. ($QNT) Buy Jun 4, 2026 $1,001 - $15,000

Key Points

  • Democratic Rep. Cleo Fields bought QNT shares valued between $1,001 and $15,000 on June 4, 2026.
  • QNT traded at $75.57 on Monday, with insiders like CFO Nitesh Sharan buying shares at $60 each.
  • Analysts from firms like Jefferies and Rosenblatt initiated QNT coverage with 'buy' ratings and targets up to $155.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Democratic Representative Cleo Fields from Louisiana's 6th district recently disclosed buying shares of QNT, valued between $1,001 and $15,000. This transaction took place on June 4, 2026, and was reported later in the month. Fields is a member of the House and represents the Democratic party.

Congressional trading track record

Cleo Fields vs. the S&P 500

YTD return +10.46% hypothetical
All-time return +26.06% S&P 500 +17.72%
vs. S&P 500 +8.34% ahead of the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

Insider Buying and Selling at Quantinuum Inc.

Several insiders at QNT made notable purchases on June 5, 2026. Michal Stepniak acquired 13,333 shares, while Joseph Jimenez bought 66,665 shares. Vimal Kapur added 13,000 shares to his holdings. Eric Branderiz purchased 8,334 shares, and Prineha Narang acquired 200 shares. Notably, Nitesh Sharan, the Chief Financial Officer, bought 6,500 shares. All these transactions were made at an average price of $60 per share and were not part of a pre-planned trading scheme.

Analysts Set New Price Targets

On June 29, 2026, several analysts initiated coverage on QNT with positive outlooks. Jefferies and Cantor Fitzgerald both started with 'buy' ratings and set a price target of $90. Craig-Hallum and B of A Securities also recommended 'buy', with targets of $100. Meanwhile, Rosenblatt was more optimistic, setting a target of $155. Mizuho and Evercore ISI Group joined in with 'buy' ratings and targets of $90 and $98, respectively. Needham also supported the stock with a $100 target.

Bottom Line

Cleo Fields' purchase of QNT shares, alongside significant insider buying, suggests confidence in the company's prospects. The stock's current trading price and the range of analyst price targets indicate varying levels of optimism about its future performance. While 13F filings and insider transactions provide valuable insights, they are historical and may not reflect the latest positions or market conditions.

Get Quantinuum Inc. alerts

New 13F filings, insider trades, and analyst moves on $QNT, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.